These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 29734788)

  • 1. YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting.
    Lo Sardo F; Strano S; Blandino G
    Cancers (Basel); 2018 May; 10(5):. PubMed ID: 29734788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting YAP/TAZ in Combination with PD-L1 Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC).
    Papavassiliou KA; Marinos G; Papavassiliou AG
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YAP/TAZ: a promising target for squamous cell carcinoma treatment.
    Dong X; Meng L; Liu P; Ji R; Su X; Xin Y; Jiang X
    Cancer Manag Res; 2019; 11():6245-6252. PubMed ID: 31360073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yes-associated protein (YAP) and transcriptional coactivator with a PDZ-binding motif (TAZ): a nexus between hypoxia and cancer.
    Zhao C; Zeng C; Ye S; Dai X; He Q; Yang B; Zhu H
    Acta Pharm Sin B; 2020 Jun; 10(6):947-960. PubMed ID: 32642404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-582-5p Is a Tumor Suppressor microRNA Targeting the Hippo-YAP/TAZ Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhu B; V M; Finch-Edmondson M; Lee Y; Wan Y; Sudol M; DasGupta R
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33670427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
    Juan WC; Hong W
    Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer.
    Lee NH; Kim SJ; Hyun J
    Biomedicines; 2021 Mar; 9(4):. PubMed ID: 33808155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Potential Role of YAP/TAZ in the Interplay Between Metastasis and Metabolic Alterations.
    Yamaguchi H; Taouk GM
    Front Oncol; 2020; 10():928. PubMed ID: 32596154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hippo Signaling Core Components YAP and TAZ as New Prognostic Factors in Lung Cancer.
    Jiang Y; Xie WJ; Chen RW; You WW; Ye WL; Chen H; Chen WX; Xu JP
    Front Surg; 2022; 9():813123. PubMed ID: 35388363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into YAP/TAZ nucleo-cytoplasmic shuttling: new cancer therapeutic opportunities?
    Shreberk-Shaked M; Oren M
    Mol Oncol; 2019 Jun; 13(6):1335-1341. PubMed ID: 31050214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial Expression of YAP and TAZ Is Sequentially Required in Lung Development.
    Isago H; Mitani A; Mikami Y; Horie M; Urushiyama H; Hamamoto R; Terasaki Y; Nagase T
    Am J Respir Cell Mol Biol; 2020 Feb; 62(2):256-266. PubMed ID: 31486675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional co-activators YAP/TAZ: Potential therapeutic targets for metastatic breast cancer.
    Zhao W; Wang M; Cai M; Zhang C; Qiu Y; Wang X; Zhang T; Zhou H; Wang J; Zhao W; Shao R
    Biomed Pharmacother; 2021 Jan; 133():110956. PubMed ID: 33189066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer.
    Noguchi S; Saito A; Nagase T
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of a component of the Hippo pathway, TAZ, in human uterine endometrioid adenocarcinoma.
    Zhan M; Ikeda JI; Wada N; Hori Y; Nojima S; Tahara SI; Ueda Y; Yoshino K; Kimura T; Morii E
    Oncol Lett; 2016 Jun; 11(6):3611-3616. PubMed ID: 27284362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between Keloid Formation and YAP/TAZ Signaling.
    Aramaki-Hattori N; Okabe K; Hamada M; Takato T; Kishi K
    Plast Reconstr Surg Glob Open; 2017 Jun; 5(6):e1357. PubMed ID: 28740772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelioid Hemangioendothelioma as a Model of YAP/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma.
    Lamar JM; Motilal Nehru V; Weinberg G
    Cancers (Basel); 2018 Jul; 10(7):. PubMed ID: 29996478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry.
    Azad T; Ghahremani M; Yang X
    Cells; 2019 May; 8(5):. PubMed ID: 31052445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hippo signaling pathway provides novel anti-cancer drug targets.
    Bae JS; Kim SM; Lee H
    Oncotarget; 2017 Feb; 8(9):16084-16098. PubMed ID: 28035075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YAP and endothelin-1 signaling: an emerging alliance in cancer.
    Tocci P; Blandino G; Bagnato A
    J Exp Clin Cancer Res; 2021 Jan; 40(1):27. PubMed ID: 33422090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippo Pathway and YAP Signaling Alterations in Squamous Cancer of the Head and Neck.
    Santos-de-Frutos K; Segrelles C; Lorz C
    J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31817001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.